Atrion Co. (NASDAQ:ATRI) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC decreased its holdings in Atrion Co. (NASDAQ:ATRI) by 23.4% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 239 shares of the medical instruments supplier’s stock after selling 73 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Atrion were worth $91,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Copeland Capital Management LLC raised its stake in shares of Atrion by 56.4% in the 4th quarter. Copeland Capital Management LLC now owns 86 shares of the medical instruments supplier’s stock valued at $33,000 after acquiring an additional 31 shares during the period. SG Americas Securities LLC purchased a new position in Atrion in the fourth quarter valued at about $108,000. First Financial Corp IN acquired a new position in shares of Atrion during the fourth quarter worth about $136,000. WINTON GROUP Ltd purchased a new stake in shares of Atrion in the third quarter worth about $208,000. Finally, Exchange Traded Concepts LLC acquired a new stake in shares of Atrion in the third quarter valued at about $333,000. 66.19% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered Atrion from a “hold” rating to a “sell” rating in a research report on Monday, April 22nd.

Atrion Trading Up 6.3 %

ATRI opened at $420.00 on Tuesday. Atrion Co. has a twelve month low of $274.98 and a twelve month high of $622.99. The firm has a market cap of $739.20 million, a price-to-earnings ratio of 38.08 and a beta of 0.60. The company has a fifty day simple moving average of $406.12 and a 200 day simple moving average of $364.66.

Atrion (NASDAQ:ATRI) last released its earnings results on Thursday, February 29th. The medical instruments supplier reported $3.65 EPS for the quarter. Atrion had a return on equity of 8.07% and a net margin of 11.46%. The company had revenue of $43.58 million during the quarter.

Atrion Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 29th. Shareholders of record on Friday, March 15th were issued a dividend of $2.20 per share. This represents a $8.80 annualized dividend and a yield of 2.10%. The ex-dividend date of this dividend was Thursday, March 14th. Atrion’s dividend payout ratio is currently 79.78%.

Atrion Company Profile

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.